184 related articles for article (PubMed ID: 37359943)
1. Synchronous Pleural and Peritoneal Mesothelioma: a Case Report and Narrative Review.
Alberto Vilchez ME; Pachmayr E; Arnold A; Gül-Klein S; Brandl A; Rau B
Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):97-105. PubMed ID: 37359943
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastases With Malignant Peritoneal Mesothelioma: Never Reported Before.
Lal D; Misiura M; Adeel W; Tariq R
Cureus; 2023 Aug; 15(8):e43744. PubMed ID: 37727202
[TBL] [Abstract][Full Text] [Related]
3. Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature.
Mino JS; Monteiro R; Pigalarga R; Varghese S; Guisto L; Rezac C
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24501333
[TBL] [Abstract][Full Text] [Related]
4. Tongue: the unusual site in malignant pleural mesothelioma.
Mohamed IZB; Idle M; Bates T; Yahya S
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33846190
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Malignant Peritoneal Mesothelioma.
Levý M; Boublíková L; Büchler T; Šimša J
Klin Onkol; 2019; 32(5):333-337. PubMed ID: 31610664
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
7. Malignant peritoneal mesothelioma: clinicopathological characteristics of two cases.
Algın MC; Yaylak F; Bayhan Z; Aslan F; Bayhan NA
Case Rep Surg; 2014; 2014():748469. PubMed ID: 24716080
[TBL] [Abstract][Full Text] [Related]
8. Multicystic and diffuse malignant peritoneal mesothelioma in children.
Vermersch S; Arnaud A; Orbach D; Andre N; Berger C; Kepenekian V; Brigand C; Fresneau B; Poli-Merol ML; Habougit C; Varlet F; Scalabre A
Pediatr Blood Cancer; 2020 Jun; 67(6):e28286. PubMed ID: 32277799
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nationwide study over 14 years.
Scalabre A; Philippe-Chomette P; Passot G; Orbach D; Elias D; Corradini N; Brugières L; Msika S; Leclair MD; Joseph S; Brigand C; Becmeur F; Soler C; Pezet D; Gagniere J; Glehen O; Sarnacki S
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286576
[TBL] [Abstract][Full Text] [Related]
10. Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
Votanopoulos KI; Sugarbaker P; Deraco M; Morris D; Glehen O; Elias D; De Simone M; Robella M; Heyd B; Kusamura S; Baratti D; Chouliaras K; Russell G; Shen P; Levine EA;
Ann Surg Oncol; 2018 Mar; 25(3):667-673. PubMed ID: 29260418
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma.
Tan GH; Cheung M; Chanyaputhipong J; Soo KC; Teo MC
Ann Acad Med Singap; 2013 Jun; 42(6):291-6. PubMed ID: 23842770
[TBL] [Abstract][Full Text] [Related]
12. Communicating imaging findings in peritoneal mesothelioma: the impact of 'PAUSE' on surgical decision-making.
Chandramohan A; Shah N; Thrower A; Carr NJ; Mittal R; Mohamed F; Moran B
Insights Imaging; 2021 Nov; 12(1):174. PubMed ID: 34817720
[TBL] [Abstract][Full Text] [Related]
13. Malignant peritoneal mesothelioma: a review.
Kim J; Bhagwandin S; Labow DM
Ann Transl Med; 2017 Jun; 5(11):236. PubMed ID: 28706904
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations.
Enomoto LM; Shen P; Levine EA; Votanopoulos KI
Cancer Manag Res; 2019; 11():4231-4241. PubMed ID: 31190990
[TBL] [Abstract][Full Text] [Related]
15. Metastases to the oral region from pleural mesothelioma: Clinicopathologic review.
Sinon SH; Rich AM; Hussaini HM; Yoon HS; Firth NA; Seymour GJ
Head Neck; 2013 Apr; 35(4):599-604. PubMed ID: 22083802
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal mesothelioma in Sweden: A population-based study.
Cashin PH; Jansson Palmer G; Asplund D; Graf W; Syk I
Cancer Med; 2019 Oct; 8(14):6468-6475. PubMed ID: 31483564
[TBL] [Abstract][Full Text] [Related]
17. [Malignant peritoneal mesothelioma: a case report].
Rezaei Kalantari H
Rev Med Liege; 2010 Sep; 65(9):490-2. PubMed ID: 21086578
[TBL] [Abstract][Full Text] [Related]
18. Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Gros L; Szturz P; Diciolla A; Kirchner V; Peters S; Schaefer N; Hubner M; Digklia A
Front Oncol; 2021; 11():704295. PubMed ID: 34222029
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
[TBL] [Abstract][Full Text] [Related]
20. Malignant peritoneal mesothelioma.
Loggie BW
Curr Treat Options Oncol; 2001 Oct; 2(5):395-9. PubMed ID: 12057102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
